en · de · es · pt
melanotan-2-notes.peptides8425.com › Faq › Background And Chemical Profile — Research Overview

Background And Chemical Profile — Research Overview

By Editorial Desk · published 2026-03-29 · last reviewed 2026-05-07 · Faq

melanocortin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-05-07. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Chemical Profile

The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.

Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.

Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.

Background and Receptor Mechanism

Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan-2 at a glance

PropertyValueNotes
Molecular classSynthetic cyclic heptapeptideAnalog of alpha-MSH with an internal lactam bridge
Molecular weightApproximately 1024 daltonsFree base value; salt forms differ
AppearanceWhite to off-white powderUsually supplied as a lyophilized solid
SolubilityFreely soluble in waterPoorly soluble in nonpolar solvents
Typical storage−20 °C, dry, protected from lightRepeated freeze-thaw cycles degrade peptides

Melanotan II Background and Mechanism

Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.

Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.

Related pages on this site

Chemical Background and Receptor Activity

Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.

Further detail

Victoria confronts her father, General Byng, about the town's problems, and he instructs her to start taking her Joy again and check in on Dr. Verloc at Haworth Labs, where he is working on a permanent replacement for Joy. However, her progress is halted by a strike by the lab workers, who demand that Sally be reinstated to her position in the lab. After helping suppress the strike, Victoria confronts Dr. Verloc. Realizing that Dr. Verloc has no permanent solution and is willing to let the populace die off to "sustainable" levels, Victoria resolves to cut off the town's Joy supply to wean them off the drug. In order to achieve these, she destroys both the pill allocator and water treatment plant responsible for distributing Joy throughout the town. She is arrested and thrown in jail, where she remembers how her mother was imprisoned in India for supporting Indian independence from Britain. General Byng helps her escape, and informs her about his safe house where he has stockpiled supplies and an escape boat. Shocked at her father's cowardice and willingness to abandon the town to its fate, Victoria rejects his offer and resolves to save the town. In order to permanently stop all Joy production, she demolishes Haworth Labs, narrowly escaping its destruction. The combination of the destruction of the Joy supply and the broadcast of Uncle Jack's final recording sends Wellington Wells into complete anarchy as the enraged citizens slaughter each other.

Nondeletion forms: These defects, in general, involve a single base-pair substitution or small insertions near or upstream of the HBB gene. Deletion forms: base-pair deletions of different sizes involving the HBB gene produce syndromes such as hereditary persistence of fetal hemoglobin syndrome. Mutations are characterized as (βo) if they prevent any formation of β globin chains, and mutations are characterized as (β+) if they allow some β globin chain formation to occur.

=== Glycolysis === Glycolysis is the process of breaking down a glucose molecule into two pyruvate molecules, while storing energy released during this process as adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NADH). Nearly all organisms that break down glucose utilize glycolysis. Glucose regulation and product use are the primary categories in which these pathways differ between organisms. In some tissues and organisms, glycolysis is the sole method of energy production. This pathway is common to both anaerobic and aerobic respiration. Glycolysis consists of ten steps, split into two phases. During the first phase, it requires the breakdown of two ATP molecules. During the second phase, chemical energy from the intermediates is transferred into ATP and NADH. The breakdown of one molecule of glucose results in two molecules of pyruvate, which can be further oxidized to access more energy in later processes. Glycolysis can be regulated at different steps of the process through feedback regulation. The step that is regulated the most is the third step. This regulation is to ensure that the body is not over-producing pyruvate molecules. The regulation also allows for the storage of glucose molecules into fatty acids. There are various enzymes that are used throughout glycolysis. The enzymes upregulate, downregulate, and feedback regulate the process.

They denied that any strike had taken place in Faizabad or Jamrud, and said that these attacks were the work of the Pakistani Taliban rather than the Afghan Taliban. The drone in Swabi crashed near a girls' school, injuring a student. A quadcopter attack on a mosque in Bannu injured five worshippers. Pakistan subsequently imposed a countrywide ban on drone flights. A Pakistani soldier was killed in a drone attack on a check post in Tank District. A school was destroyed in a drone strike in North Waziristan while a 200kg+ missile exploded in an open space near a military installation in Mirali, causing no casualties. Pakistani forces foiled coordinated militant attacks on police posts in Bannu, Hangu and Peshawar districts. A constable and a civilian were injured in the attack in Peshawar. During the same day, Pakistan's army spokesperson stated that Operation Ghazab Lil Haq was continuing successfully against the Afghan Taliban. He said Pakistani forces had repulsed insurgents at 53 border locations, killing 274 militants, injuring more than 400. He added that 73 Afghan Taliban posts had been destroyed, 18 had been captured, and 115 tanks and armoured vehicles had also been destroyed. He also said Pakistani forces had targeted militant infrastructure at 22 locations in Kandahar, Paktia, Nangarhar, Khost, and Paktika. He added that 12 Pakistani soldiers were killed, 27 were wounded, and one is missing in action. Pakistani officials also released videos of their strikes in Afghanistan.

Sources: en.wikipedia.org

Background from the literature

=== Discontinued === Alniditan (R-91274) – serotonin 5-HT1B and 5-HT1D receptor agonist – migraine [72] Avitriptan (BMS-180048) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [73] Bezisterim (HE-3286; NE-3107; Triolex; 17α-ethynyl-5-androstene-3β,7β,17β-triol) – undefined mechanism of action (synthetic androstenetriol analogue and anti-inflammatory) – migraine [74] BI-44370 (BI44370) – calcitonin gene-related peptide receptor (CGRPR) antagonist – migraine [75] Botulinum toxin A topical (RT-001) – acetylcholine release inhibitor and neuromuscular blocking agent – migraine [76] Carisbamate (Comfyde; JNJ-10234094; RWJ-333369; YKP-509) – unknown mechanism of action – migraine [77] Dasolampanel (NGX-426) – ionotropic glutamate AMPA and kainate receptor antagonist – migraine [78] Dextromethorphan/quinidine (DXM/Q; AVP-923; Neurodex; Nuedexta; Zenvia) – combination of dextromethorphan (various actions) and quinidine (various actions) – migraine [79] Dihydroergocryptine (SRN-001) – non-selective monoamine receptor modulator and ergoline – migraine [80] Donitriptan (F-11356) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [81] Dotarizine (Dotaricin; FI-6026) – calcium channel blocker and serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptor antagonist – migraine [82] Dronabinol (Δ9-THC; Δ9-tetrahydrocannabinol; Deltanyne; Elevat; Marinol) – cannabinoid CB1 and CB2 receptor agonist – migraine [83] Ergotamine inhalation (Tempo-ergotamine) – non-selective monoamine receptor modulator and ergoline – migraine [84] Esprolol ((S)-ACC-9369) – beta blocker (β-adrenergic receptor antagonist) (amoxolol prodrug) – migraine [85] Ethinylestradiol/levonorgestrel (DP3; DR-103; DR-105; LoSeasonique; Seasonique) – combination of ethinylestradiol (an estrogen) and levonorgestrel (a progestogen) and a combined oral contraceptive – menstrual migraine [86] (S)-Ethylisothiouronium diethylphosphate (Difetur; MTR-104; MTR-105; MTR-106; MTR-107; MTR-108; Raviclust; Ravimig; Raviten) – nitric oxide synthase (NOS) inhibitor [87] Fremanezumab (Ajovy; LBR-101; PF-04427429; PF-4427429; RN-307; TEV-48125) – monoclonal antibody against calcitonin gene-related peptide (CGRP) – cluster headache, headache [88] Gabapentin (CI-945; Gabapen; GOE-3450; Neurontin) – gabapentinoid (α2δ subunit-containing voltage-gated calcium channel ligand) – migraine [89] Gabapentin enacarbil (1838262; ASP8825; GSK-1838262; Horizant; Regnite; Solzira; XP13512) – gabapentinoid (α2δ subunit-containing voltage-gated calcium channel ligand) – migraine [90] Ganaxolone (CCD-1042; Ztalmy) – GABAA receptor positive allosteric modulator and neurosteroid – migraine [91] HTL-0022562 (BHV-3100; HTL-22562) – calcitonin gene-related peptide receptor (CGRPR) antagonist – migraine [92] IS-159 – serotonin 5-HT1B and 5-HT1D receptor agonist – migraine [93] Lacosamide (ADD-234037; Erlosamide; Harkoseride; SPM-927; SPM-929; Vimpat; Vimpato) – various actions – migraine [94] Lanepitant (LY-303870) – neurokinin NK1 receptor antagonist – migraine [95] Lidocaine transdermal patch (ADL-87223; LidoPAIN) – sodium channel blocker – headache [96] Lornoxicam (Bosporon; Chlortenoxicam; HN-10000; RO-139297; Safem; TS-110; Xefo) – COX inhibitor/NSAID – migraine [97] LY-2300559 – metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator and cysteinyl leukotriene receptor 1 (CysLTR1) antagonist – migraine [98] LY-334370 – serotonin 5-HT1F receptor agonist and triptan – migraine [99] MEDI-0618 – monoclonal antibody against protease-activated receptor 2 (PAR2) – migraine [100] Olcegepant (BIBN-4096; BIBN-4096BS) – calcitonin gene-related peptide receptor (CGRPR) antagonist – migraine [101] Oxytocin (TI-001; TI-114; TNX-1900; TNX-2900) – oxytocin receptor agonist – migraine [102] Perampanel (E-2007; ER-155055-90; Fycompa) – AMPA receptor antagonist – migraine [103] PF-5180999 (PF-05180999) – phosphodiesterase PDE2 inhibitor – migraine [104] PNU-142633 (PNU-142633F) – serotonin 5-HT1D receptor agonist – cluster headache, headache, migraine [105] Prochlorperazine inhalation (AZ-001) – typical antipsychotic (non-selective monoamine receptor modulator) – migraine [106] Propisergide (ergalgin) – serotonin receptor modulator and ergoline – migraine Propofol phosphate (Neuprox; propofol prodrug) – GABAA receptor positive allosteric modulator (propofol prodrug) – migraine [107] Research programme: migraine therapy - Orexo (OX-40; OX641) – undefined mechanism of action – migraine [108] Selurampanel (BGG-492; BGG-492A) – ionotropic glutamate AMPA and kainate receptor antagonist – migraine [109] Sergolexole (LY-281067) – serotonin 5-HT2 receptor antagonist and ergoline – migraine [110] Telcagepant (MK-0974) – calcitonin gene-related peptide receptor (CGRPR) antagonist – migraine [111] Tezampanel (LY-293558; NGX-424; PRN-001-01) – ionotropic glutamate AMPA and kainate receptor antagonist – migraine [112] Tizanidine (AN-021A; AN-021; DS-103282; Sirdalud; Ternelin; Zanaflex) – α2-adrenergic receptor agonist – migraine [113] Tonabersat (SB-220453; USL-260; Xiflam) – connexin 43 (GJA1) inhibitor – migraine [114] Zolmitriptan inhalation (CVT-427) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [115] Zonisamide (AD-810; CI-912; Excegran; Kinaplase; PD-110843; Tremode; Trerief; Zonegran) – calcium channel blocker, sodium channel blocker, and other actions – migraine [116]

In plants, algae, cyanobacteria, and phototrophic and chemoautotrophic Pseudomonadota (formerly referred to as proteobacteria), the enzyme usually consists of two types of protein subunit, called the large chain (L, about 55,000 Da) and the small chain (S, about 13,000 Da). The large-chain gene (rbcL) is encoded by the chloroplast DNA in plants. There are typically several related small-chain genes in the nucleus of plant cells, and the small chains are imported to the stromal compartment of chloroplasts from the cytosol by crossing the outer chloroplast membrane. The enzymatically active substrate (ribulose 1,5-bisphosphate) binding sites are located in the large chains that form dimers in which amino acids from each large chain contribute to the binding sites. A total of eight large chains (= four dimers) and eight small chains assemble into a larger complex of about 540,000 Da. In some Pseudomonadota and dinoflagellates, enzymes consisting of only large subunits have been found. Magnesium ions (Mg2+) are needed for enzymatic activity. Correct positioning of Mg2+ in the active site of the enzyme involves addition of an "activating" carbon dioxide molecule (CO2) to a lysine in the active site (forming a carbamate). Mg2+ operates by driving deprotonation of the Lys210 residue, causing the Lys residue to rotate by 120 degrees to the trans conformer, decreasing the distance between the nitrogen of Lys and the carbon of CO2. The close proximity allows for the formation of a covalent bond, resulting in the carbamate.

=== 18 January === Australian defence minister Richard Marles stated that Australian soldiers would be deployed in the UK to train Ukrainian soldiers in "infantry tactics in an urban, wooded and basic" settings.

== Platform technologies == Rosetta Genomics has developed several proprietary technologies that enable the company to work with microRNAs. At the basis of these technologies are proprietary microRNA extraction protocols that include sensitive extraction of microRNAs from most body fluids, including serum, urine, saliva, with virtually no microRNA lost in the extraction process. The company has also developed a microRNA extraction protocol from Formalin Fixed Paraffin Embedded, or FFPE, samples. This allows extraction of microRNAs from samples preserved at room temperature. Once microRNAs are extracted, Rosetta Genomics’ technology is capable of detecting and quantifying the microRNAs using two custom designed platform technologies which utilize Quantitative Real Time PCR (or qRT-PCR) and microarrays. The company's proprietary microarray platform covers approximately 850 human microRNAs, including approximately 180 microRNAs which are Rosetta Genomics’ proprietary microRNAs. The array's high specificity allows discriminating homologous family members.

== Use == A common way to synthesize an NHS-activated acid is to mix NHS with the desired carboxylic acid and a small amount of an organic base in an anhydrous solvent. A coupling reagent such as dicyclohexylcarbodiimide (DCC) or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) is then added to form a highly reactive activated acid intermediate. NHS reacts to create a less labile activated acid. The group is usually written as SuO- or -OSu in chemical notation. Such an ester with acid and NHS, sometimes called succinate ester, is stable enough to be purified and stored at low temperatures in the absence of water and, as such, is commercially available. NHS esters are commonly used for protein modification (e.g. an NHS ester of fluorescein is commercially available, and can be added to a protein to obtain a fluorescently labeled protein in a straightforward reaction and purification step). NHS can be used with EDC to immobilize enzymes for biosensor applications.

Sources: en.wikipedia.org

Further detail

Binge drinking, or heavy episodic drinking, is drinking alcoholic beverages with an intention of becoming intoxicated by heavy consumption of alcohol over a short period of time. Specific definitions vary considerably. Binge drinking is associated with risks such as suicide, sexual assault, cardiovascular issues, and brain damage, more acutely than alcohol use in general.

=== Cancer === Bleomycin is mostly used to treat testicular cancer, ovarian cancer, and Hodgkin's disease, and less commonly non-Hodgkin's disease. It can be given intravenously, by intramuscular injection, or under the skin.

== Genomics == The human OTC gene is located on the short arm of chromosome X (Xp21.1). The gene is located in the Watson (plus) strand and is 73 kbases in length. The open reading frame of 1,062 nucleotides is disbursed between 10 exons and nine introns. The encoded protein is 354 amino acids long with a predicted molecular weight of 39.935 kD. Postranscriptional modification leaves the mature peptide with 322 amino acids and a weight of 36.1 kD. The protein is located in the mitochondrial matrix. In mammals, OTC is expressed in the liver and small intestinal mucosa.

The energy required to transform B, C, N, Si, and P from nonmetallic to metallic states has been estimated as 30, 100, 240, 33, and 50 kJ/mol, respectively. This indicates the proximity of boron to the metal-nonmetal borderline. Most of the chemistry of boron is nonmetallic in nature. Unlike its heavier congeners, it is not known to form a simple B3+ or hydrated [B(H2O)4]3+ cation. The small size of the boron atom enables the preparation of many interstitial alloy-type borides. Analogies between boron and transition metals have been noted in the formation of complexes, and adducts (for example, BH3 + CO →BH3CO and, similarly, Fe(CO)4 + CO →Fe(CO)5), as well as in the geometric and electronic structures of cluster species such as [B6H6]2− and [Ru6(CO)18]2−. The aqueous chemistry of boron is characterised by the formation of many different polyborate anions. Given its high charge-to-size ratio, boron bonds covalently in nearly all of its compounds; the exceptions are the borides as these include, depending on their composition, covalent, ionic, and metallic bonding components. Simple binary compounds, such as boron trichloride are Lewis acids as the formation of three covalent bonds leaves a hole in the octet which can be filled by an electron-pair donated by a Lewis base. Boron has a strong affinity for oxygen and a duly extensive borate chemistry. The oxide B2O3 is polymeric in structure, weakly acidic, and a glass former. Organometallic compounds of boron have been known since the 19th century (see organoboron chemistry).

== Personal life == On 17 October 2009 McVeigh married his longtime girlfriend, Leanne Tucker. They have a daughter, Ariana, born in March 2011. Mark also had a niece, Luella (the daughter of Sydney's Jarrad McVeigh), born on 25 July 2011 but she died from heart complications barely a month later. Following Essendon's seven-point victory over Port Adelaide, its first over the side since 2004, Mark 'blew a kiss towards to the heavens' in her memory. Essendon's players wore black armbands in the match.

Sources: en.wikipedia.org

Frequently asked questions

What is melanotan-2?

It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.

How does it differ from melanotan-1?

Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.

Is it the same as bremelanotide?

No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.

Is melanotan II an approved medication?

No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.

Network